Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature

Publisher: John Wiley & Sons Inc

E-ISSN: 1600-0609|94|6|554-557

ISSN: 0902-4441

Source: EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.94, Iss.6, 2015-06, pp. : 554-557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract